Chugai Pharmaceutical
2-1-1 Nihonbashi-Muromachi,
Tokyo, 103-8324,
Japan
Tokyo, 103-8324,
Japan
81 3 3281 6611
Life Sciences
Chugai Pharmaceutical Technographics
Chugai Pharmaceutical Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Chugai Pharmaceutical and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 7604 Chugai Pharmaceutical employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Chugai Pharmaceutical has purchased the following applications: IDBS E-WorkBook for Content Management in 2016, Ptengine Insight for Marketing Analytics in 2022, Amazon SES for Transactional Email in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Chugai Pharmaceutical is running and its propensity to invest more and deepen its relationship with IDBS , DocuSign , Ptengine or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Chugai Pharmaceutical revenues, which have grown to $7.13 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Chugai Pharmaceutical intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Chugai Pharmaceutical Tech Stack and Enterprise Applications
Chugai Pharmaceutical Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| IDBS | Legacy | IDBS E-WorkBook | Content Management | Content Management | ITOCHU Techno-Solutions Corporation | 2016 | 2016 |
In 2016, Chugai Pharmaceutical implemented IDBS E-WorkBook as a Content Management solution to reduce reliance on paper notebooks and mitigate the risk natural disasters posed to physical records. The decision followed internal consultations with Roche and a Chemistry Department manager who had prior ELN experience, and it targeted reduced paper use and fewer physical record storage areas across the Research Division.
The deployment used a user-buy-in rollout rather than a top-down mandate, beginning with a six month pilot in oncology pharmacology groups where teams analyzed practical workflows and how to link existing paper documents to electronic experiments. IDBS E-WorkBook was configured to capture scanned handwritten notes, drag-and-drop instrument files and PDFs, and structured SOP-driven experiment templates, while initial return on investment was measured during the pilot. The vendor IDBS worked alongside regional partner CTC Life Sciences Corporation and implementation partner ITOCHU Techno-Solutions Corporation to provide domain expertise and training, with simple introductory sessions followed later by hands-on training for larger cohorts.
Integrations implemented included direct links from ELN entries to servers hosting raw instrument data, enabling traceability back to original files and faster retrieval via keyword search. Operational coverage focused on the Research Division with explicit adoption in pharmacology, analytical instrument groups, and pre-formulation teams, and a planned production rollout to the entire research division and subsidiaries outside Japan throughout 2016. Governance emphasized a high-level roadmap, group kick-off meetings to surface operational issues, department-level business analysis, and flexible migration from paper with no fixed go-live date to allow users to transition when appropriate.
Chugai reported explicit productivity and efficiency outcomes after deployment, including productivity gains of 20 to 30 percent for pharmacology scientists, up to 50 percent for pre-formulation groups on SOP-driven work, and 30 percent efficiency improvements for analytical groups. The implementation increased the depth and quality of experimental records through easier attachment of raw data and instrument screenshots, improved searchability and witnessing, reduced physical storage requirements, and lowered operational risk associated with paper-based notebooks.
|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
Chugai Pharmaceutical CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Ptengine | Legacy | Ptengine Insight | Marketing Analytics | CRM | n/a | 2022 | 2022 |
In 2022 Chugai Pharmaceutical implemented Ptengine Insight on its corporate website, adopting Ptengine Insight as the analytics layer for web behavior capture and analysis. This deployment is categorized under Marketing Analytics and is configured to collect visitor behavior data directly from site pages for centralized analysis.
The implementation uses standard web tag deployment to instrument pageview tracking, event tracking, heatmap visualization, funnel analysis, and visitor segmentation within Ptengine Insight. Configuration emphasizes behavioral analytics modules and dashboarding, enabling digital marketing teams to inspect session-level interactions, conversion funnels, and segmented cohorts in the Ptengine Insight interface.
Operational ownership is centered in digital marketing and web operations, with governance oriented around consent-aware data capture and reporting workflows aligned to corporate privacy practices in Japan. The rollout is focused on the corporate site, providing an analytics foundation for site optimization, campaign measurement, and ongoing behavioral research under the Marketing Analytics category.
|
|
|
|
|
Marketing Automation | CRM |
|
2019 | 2019 |
|
Chugai Pharmaceutical PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Amazon Web Services (AWS) | Legacy | Amazon SES | Transactional Email | PaaS | n/a | 2021 | 2021 |
In 2021, Chugai Pharmaceutical implemented Amazon SES for Transactional Email on its public website, with Amazon Web Services listed as the vendor. The deployment is focused on powering website generated outbound messages, including transactional notifications and contact form deliveries, using Amazon SES as the SMTP and API based sending service.
Technical configuration centers on integrating Amazon SES with the website through SMTP and API endpoints, using template driven message rendering, and enabling bounce and complaint handling workflows to manage deliverability. The implementation includes email authentication via SPF and DKIM records and domain verification to centralize the sending domain and align web facing notifications with corporate identity. Operational scope is limited to website generated transactional messages, aligning the Transactional Email capability with customer communication and site notification business functions.
|
Chugai Pharmaceutical IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
Chugai Pharmaceutical CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at Chugai Pharmaceutical
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Chugai Pharmaceutical Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Chugai Pharmaceutical IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Chugai Pharmaceutical digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Chugai Pharmaceutical Technographics
Chugai Pharmaceutical is a Life Sciences organization based in Japan,
with around 7604 employees and annual revenues of $7.13 billion.
Chugai Pharmaceutical operates a diverse technology stack with applications such as
IDBS E-WorkBook, Ptengine Insight and Amazon SES,
covering areas like Content Management, Marketing Analytics and Transactional Email.
Chugai Pharmaceutical has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as IDBS, Ptengine and Amazon Web Services (AWS).
Chugai Pharmaceutical recently adopted applications including
Ptengine Insight in 2022, Amazon CloudFront in 2022 and DocuSign eSignature in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Chugai Pharmaceutical’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Chugai Pharmaceutical’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Chugai Pharmaceutical technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.